|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 3.290 NOK | 0.00% |
|
-1.79% | +36.40% |
| 08-06 | Nykode Therapeutics Asa Announces Appointment of Jakob Helding Rasmussen as Chief Technology Officer | CI |
| 08-04 | Nykode Therapeutics Flags Delay in Draft Recommendation for Tax Appeal in Norway | MT |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
Sector Bio Therapeutic Drugs
| Capi. | Sales Growth | Profitability | Finances | EV / Sales | P/E | |
|---|---|---|---|---|---|---|
 | 114M | - | - | - | - | - |
| 70.85B | |||||
| 55.41B | |||||
| 29.43B | - | ||||
| 24.12B | |||||
| 23.31B | - |
- Stock Market
- Stocks
- VACC Stock
- Charts Nykode Therapeutics
- Sector Chart
Select your edition
All financial news and data tailored to specific country editions
